Your search found 6 VIDEOS, WORKSHOPS, and WEBINARS.

Article (Peer-Reviewed)

1. Barriers and Facilitators Affecting the Implementation of Substance Use Screening in Primary Care Clinics: A Qualitative Study of Patients, Providers, and Staff. doc type
  McNeely, Jennifer ; Kumar, Pritika C. ; Rieckmann, Traci R. ; Sedlander, Erica ; Farkas, Sarah ; Chollak, Christine ; Kannry, Joseph L. ; Vega, Aida ; Waite, Eva A. ; Peccoralo, Lauren A. ; Rosenthal, Richard N. ; McCarty, Dennis ; Rotrosen, John
 Addiction Science & Clinical Practice 2018;13:8. [doi: 10.1186/s13722-018-0110-8].
 
2. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2018;391(10118):309-318. [doi: 10.1016/S0140-6736(17)32812-X].
 
3. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 

Poster

4. Implementing Substance Use Screening in Rural Federally-Qualified Health Centers: Results from Focus Groups. doc type
  McLeman, Bethany ; McNeely, Jennifer ; Saunders, Elizabeth C. ; Farkas, Sarah ; Walsh, Olivia ; Meier, Andrea ; Gardner, Trip ; Nesin, Noah ; Higgins, Seamus ; Marsch, Lisa A.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
5. Comparative Effectiveness of Extended-Release Naltrexone versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicenter, Open-Label, Randomized Controlled Trial. doc type
  Novo, Patricia ; Lee, Joshua D. ; Nunes, Edward V. ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 

Presentation

6. Usability Testing to Guide Development of a Clinical Decision Support System for Substance Use Screening and Interventions in Primary Care. doc type
  McNeely, Jennifer ; Kushniruk, Andre ; Farkas, Sarah ; Vega, Aida ; Waite, Eva ; Peccoralo, Lauren A. ; Harris, Melanie ; Chollak, Christine ; Rosenthal, Richard N. ; Rotrosen, John ; Kannry, Joseph
 Presented at the American Medical Informatics Association (AMIA) annual symposium Washington, DC., November 4-8, 2017.
 


Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO